This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Clinical adverse events on penicillamine

Authoring team

  • Rash

Often non-specific erythematous dry & itchy. Stop drug if severe. Stop drug if bullous reaction occurs. Consider using 1% hydrocortisone and/or antihistamines. Consider other causes. If mild re-introduce when settled.

  • Mouth ulcers/Stomatitis

Stop if severe, reduce dose if mild/moderate. Consider carbenoxalone or difflam mouth washes. Consider other causes, check white cell count

  • Loss of taste

Common early in treatment. Usually reappears with time or when drug stoppped.

  • Metallic taste

Common early in treatment. Usually reappears with time or when drug stoppped. Stop if unacceptable.

  • Nausea

Reduce dose and take with food. Stop if unacceptable.

  • Lupus syndrome

Rare and difficult to diagnose. Stop drug and seek advice.

  • Dyspnoea/Bronchiolitis

Stop drug and seek advice

  • Myaesthenic symptoms

Stop drug and seek advice


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.